What is the share price of Dr Lalchandani Labs Ltd (DLCL) today?
The share price of DLCL as on 5th June 2025 is ₹14.05. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Dr Lalchandani Labs Ltd (DLCL) share?
The past returns of Dr Lalchandani Labs Ltd (DLCL) share are- Past 1 week: 15.53%
- Past 1 month: 21.07%
- Past 3 months: -0.81%
- Past 6 months: -23.44%
- Past 1 year: -40.04%
- Past 3 years: -48.30%
- Past 5 years: 39.48%
What are the peers or stocks similar to Dr Lalchandani Labs Ltd (DLCL)?
The peers or stocks similar to Dr Lalchandani Labs Ltd (DLCL) include:What is the market cap of Dr Lalchandani Labs Ltd (DLCL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr Lalchandani Labs Ltd (DLCL) is ₹5.80 Cr as of 5th June 2025.What is the 52 week high and low of Dr Lalchandani Labs Ltd (DLCL) share?
The 52-week high of Dr Lalchandani Labs Ltd (DLCL) is ₹28.90 and the 52-week low is ₹9.80.What is the PE and PB ratio of Dr Lalchandani Labs Ltd (DLCL) stock?
The P/E (price-to-earnings) ratio of Dr Lalchandani Labs Ltd (DLCL) is 14.15. The P/B (price-to-book) ratio is 0.61.Which sector does Dr Lalchandani Labs Ltd (DLCL) belong to?
Dr Lalchandani Labs Ltd (DLCL) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Dr Lalchandani Labs Ltd (DLCL) shares?
You can directly buy Dr Lalchandani Labs Ltd (DLCL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Dr Lalchandani Labs Ltd
DLCL Share Price
DLCL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
DLCL Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 0.61 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
35.25 | 6.50 | 0.86% |
DLCL Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
DLCL Company Profile
Dr Lalchandani Labs is a provider of diagnostic and related healthcare tests and services.
DLCL Similar Stocks (Peers)
Compare with peersDLCL Forecasts
DLCL Forecast
Price
Revenue
Earnings
DLCL Share Price Forecast
All values in ₹
All values in ₹
DLCL Company Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
DLCL Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
DLCL
Income
Balance Sheet
Cash Flow
DLCL Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 4.61 | 2.82 | 5.27 | 6.10 | 9.78 | 11.28 | 5.04 | 6.24 | 4.46 | — | ||||||||||
Raw Materials | 3.37 | 0.59 | 0.61 | 1.15 | 3.61 | 2.98 | 1.21 | 2.06 | 3.41 | — | ||||||||||
Power & Fuel Cost | 0.07 | 0.11 | 0.11 | 0.11 | 0.16 | 0.11 | 0.11 | |||||||||||||
Employee Cost | 0.30 | 0.67 | 0.57 | 0.42 | 1.11 | 1.11 | 0.72 | |||||||||||||
Selling & Administrative Expenses | 0.72 | 2.22 | 2.29 | 2.67 | 3.66 | 1.78 | 1.24 | |||||||||||||
Operating & Other expenses | 0.49 | 0.46 | 0.72 | 0.73 | 0.90 | 0.74 | 0.48 | |||||||||||||
EBITDA | 1.24 | 0.65 | 1.20 | 1.26 | 2.24 | 2.47 | 0.09 | 1.63 | 1.05 | — | ||||||||||
Depreciation/Amortization | 0.17 | 0.13 | 0.35 | 0.42 | 0.52 | 0.59 | 0.66 | 0.62 | 0.56 | — | ||||||||||
PBIT | 1.07 | 0.52 | 0.85 | 0.84 | 1.72 | 1.88 | -0.57 | 1.01 | 0.49 | — | ||||||||||
Interest & Other Items | 0.36 | 0.16 | 0.14 | 0.18 | 0.35 | 0.60 | 0.99 | 0.38 | 0.09 | — | ||||||||||
PBT | 0.71 | 0.36 | 0.71 | 0.66 | 1.37 | 1.28 | -1.56 | 0.63 | 0.40 | — | ||||||||||
Taxes & Other Items | 0.22 | 0.09 | 0.19 | 0.19 | 0.36 | 0.36 | 0.00 | 0.00 | -0.01 | — | ||||||||||
Net Income | 0.49 | 0.27 | 0.52 | 0.47 | 1.01 | 0.92 | -1.56 | 0.63 | 0.41 | — | ||||||||||
EPS | 35.47 | 0.92 | 1.43 | 1.08 | 2.33 | 2.12 | -3.60 | 1.45 | 0.96 | — | ||||||||||
DPS | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
DLCL Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFDLCL Past Performance & Peer Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Dr Lalchandani Labs Ltd | 14.15 | 0.61 | — |
Max Healthcare Institute Ltd | 103.79 | 13.28 | 0.13% |
Apollo Hospitals Enterprise Ltd | 68.17 | 13.46 | 0.41% |
Fortis Healthcare Ltd | 72.05 | 6.52 | 0.14% |
DLCL Stock Price Comparison
Compare DLCL with any stock or ETFDLCL Shareholdings
DLCL Promoter Holdings Trend
In last 6 months, promoter holding in the company has decreased by 8.86%
Pledged promoter holdings is insignificant
DLCL Institutional Holdings Trend
No institutional holdings trend are available
DLCL Shareholding Pattern
DLCL Shareholding History
smallcases containing DLCL stock
Looks like this stock is not in any smallcase yet.
DLCL Events
DLCL Dividend Trend
DLCL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
DLCL Dividends
DLCL Stock News & Opinions
Dr Lalchandani Labs will hold a meeting of the Board of Directors of the Company on 1 May 2025.Powered by Capital Market - Live
Dr Lalchandani Labs will hold a meeting of the Board of Directors of the Company on 14 October 2024.Powered by Capital Market - Live
Dr Lalchandani Labs announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Dr Lalchandani Labs announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Thyrocare, Vijaya, other diagnostics shares jump up to 7% amid Covid scar

Dr Lalchandani Labs receive approval to be listed as COVID-19 Vaccination Centre

Over the last 5 years, revenue has grown at a yearly rate of 3.44%, vs industry avg of 10.01%
Over the last 5 years, market share stayed at 0.01%
Over the last 5 years, net income has grown at a yearly rate of 3.91%, vs industry avg of 42.91%